Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US team identify Huntington's disease protein:

This article was originally published in Clinica

Executive Summary

Researchers from the Johns Hopkins Medical School have identified a protein involved in the development of Huntington's disease. They claim the protein, HAP-1, interacts with huntingtin, the protein product of the Huntington's disease gene which was identified in 1993. HAP-1 binds to normal huntingtin, but binds even more strongly to the disease-causing mutated huntingtin. Commenting in Nature (November 23rd), the team believes the tighter binding may change the way the proteins function leading to neuronal death.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT094413

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel